Epigenetic alterations can also lead to resistance to chemotherapy and radiotherapy, limiting their efficacy [248], and changes in the expression level of METTL3 made PCa cells resistant to AR antagonists [249]. The gene discussed is AR; the disease is posterior cortical atrophy.